Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)

Inclusion Criteria: DISEASE CHARACTERISTICS 1. Locally advanced or metastatic pancreatic cancer precluding curative surgical resection and recurrent pancreatic cancer 2. Measurable disease by CT scan PATIENTS CHARACTERISTICS 1. ECOG performance status 0-2 2. Life expectancy \> 3 months 3. Laboratory values as follows: * 2,000/mm3 \< WBC \< 15000/mm3 * Platelet count ≥ 750,000/mm³ * Total Bilirubin ≤ 1.5 x * Aspartate transaminase \< 150 IU/L * Alanine transaminase \< 150 IU/L * Creatinine ≤ 3.0 mg/dl 4. HLA-A\*2402 5. Able and willing to give valid written informed consent Exclusion Criteria: 1. Pregnancy (women of childbearing potential: Refusal or inability to use effective means of contraception) 2. Breast-feeder 3. Active or uncontrolled infection 4. Prior chemotherapy, radiation therapy, or immunotherapy within 4 weeks 5. Serious or uncured wound 6. Active or uncontrolled other malignancy 7. Steroids or immunosuppressing agent dependent status 8. Interstitial pneumonia 9. Ileus 10. Decision of unsuitableness by principal investigator or physician-in-charge